Gabra H - Search Results

1

Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer.

Sharma R, Graham J, Blagden S, Gabra H. Sharma R, et al. Among authors: gabra h. BMC Cancer. 2011 Jul 11;11:289. doi: 10.1186/1471-2407-11-289. BMC Cancer. 2011. PMID: 21745358 Free PMC article. Clinical Trial.

2

Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.

Vasey PA, Jayson GC, Gordon A, Gabra H, Coleman R, Atkinson R, Parkin D, Paul J, Hay A, Kaye SB; Scottish Gynaecological Cancer Trials Group. Vasey PA, et al. Among authors: gabra h. J Natl Cancer Inst. 2004 Nov 17;96(22):1682-91. doi: 10.1093/jnci/djh323. J Natl Cancer Inst. 2004. PMID: 15547181 Clinical Trial.

3

Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer.

Sharma R, Hook J, Kumar M, Gabra H. Sharma R, et al. Among authors: gabra h. Eur J Cancer. 2008 Jan;44(2):251-6. doi: 10.1016/j.ejca.2007.11.011. Epub 2007 Dec 26. Eur J Cancer. 2008. PMID: 18155897

4

Future directions in the management of epithelial ovarian cancer.

Blagden S, Gabra H. Blagden S, et al. Among authors: gabra h. Future Oncol. 2008 Jun;4(3):403-11. doi: 10.2217/14796694.4.3.403. Future Oncol. 2008. PMID: 18518765 Review.

5

Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer.

Sharma R, Graham J, Mitchell H, Brooks A, Blagden S, Gabra H. Sharma R, et al. Among authors: gabra h. Br J Cancer. 2009 Mar 10;100(5):707-12. doi: 10.1038/sj.bjc.6604914. Epub 2009 Feb 17. Br J Cancer. 2009. PMID: 19223898 Free PMC article.

6

A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma.

Ang JE, Shah RN, Everard M, Keyzor C, Coombes I, Jenkins A, Thomas K, A'Hern R, Jones RL, Blake P, Gabra H, Hall G, Gore ME, Kaye SB. Ang JE, et al. Among authors: gabra h. Ann Oncol. 2009 Nov;20(11):1787-93. doi: 10.1093/annonc/mdp193. Epub 2009 Jun 19. Ann Oncol. 2009. PMID: 19542250 Free article. Clinical Trial.

7

Promising molecular targets in ovarian cancer.

Blagden S, Gabra H. Blagden S, et al. Among authors: gabra h. Curr Opin Oncol. 2009 Sep;21(5):412-9. doi: 10.1097/CCO.0b013e32832eab1f. Curr Opin Oncol. 2009. PMID: 19553815 Review.

8

Dose density and altered scheduling of adjuvant chemotherapy in ovarian cancer: teaching old dogs new tricks?

Gabra H. Gabra H. Discov Med. 2009 Oct;8(42):140-4. Discov Med. 2009. PMID: 19833062 Free article.

9

An unusual case of sex cord tumor with annular tubules with malignant transformation in a patient with Peutz-Jeghers syndrome.

Barker D, Sharma R, McIndoe A, Blair E, Hall M, Gabra H, El-Bahrawy M. Barker D, et al. Among authors: gabra h. Int J Gynecol Pathol. 2010 Jan;29(1):27-32. doi: 10.1097/PGP.0b013e3181b6a7c2. Int J Gynecol Pathol. 2010. PMID: 19952941

10

First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series.

Agarwal R, Gourley C, Perren TJ, Reed N, Parkin DE, Carty K, Rustin GJ, Gabra H, Paul J, Gore ME, Kaye SB; Scottish Gynecological Cancers Trials Group. Agarwal R, et al. Among authors: gabra h. Eur J Cancer. 2010 Jul;46(11):2020-6. doi: 10.1016/j.ejca.2010.03.006. Epub 2010 Apr 13. Eur J Cancer. 2010. PMID: 20395128 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters